Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters

Neuropsychopharmacology. 2004 Oct;29(10):1790-9. doi: 10.1038/sj.npp.1300476.

Abstract

Cocaine conditioned place preference (CPP) is intact in dopamine transporter (DAT) knockout (KO) mice and enhanced in serotonin transporter (SERT) KO mice. However, cocaine CPP is eliminated in double-KO mice with no DAT and either no or one SERT gene copy. To help determine mechanisms underlying these effects, we now report examination of baselines and drug-induced changes of extracellular dopamine (DAex) and serotonin (5-HT(ex)) levels in microdialysates from nucleus accumbens (NAc), caudate putamen (CPu), and prefrontal cortex (PFc) of wild-type, homozygous DAT- or SERT-KO and heterozygous or homozygous DAT/SERT double-KO mice, which are differentially rewarded by cocaine. Cocaine fails to increase DAex in NAc of DAT-KO mice. By contrast, systemic cocaine enhances DAex in both CPu and PFc of DAT-KO mice though local cocaine fails to affect DAex in CPu. Adding SERT to DAT deletion attenuates the cocaine-induced DAex increases found in CPu, but not those found in PFc. The selective SERT blocker fluoxetine increases DAex in CPu of DAT-KO mice, while cocaine and the selective DAT blocker GBR12909 increase 5-HT(ex) in CPu of SERT-KO mice. These data provide evidence that (a) cocaine increases DAex in PFc independently of DAT and that (b), in the absence of SERT, CPu levels of 5-HT(ex) can be increased by blocking DAT. Cocaine-induced alterations in CPu DA levels in DAT-, SERT-, and DAT/SERT double-KO mice appear to provide better correlations with cocaine CPP than cocaine-induced DA level alterations in NAc or PFc.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism
  • Cocaine / pharmacology
  • Dopamine / metabolism*
  • Dopamine Plasma Membrane Transport Proteins
  • Dopamine Uptake Inhibitors / pharmacology
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Fluoxetine / pharmacology
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / physiology*
  • Membrane Transport Proteins / genetics
  • Membrane Transport Proteins / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microdialysis
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism
  • Piperazines / pharmacology
  • Prefrontal Cortex / metabolism
  • Putamen / drug effects
  • Putamen / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Serotonin / metabolism*
  • Serotonin Plasma Membrane Transport Proteins
  • Stereotaxic Techniques

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Dopamine Uptake Inhibitors
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Piperazines
  • Serotonin Plasma Membrane Transport Proteins
  • Slc6a3 protein, mouse
  • Slc6a4 protein, mouse
  • Fluoxetine
  • Serotonin
  • vanoxerine
  • Cocaine
  • Dopamine